Last reviewed · How we verify

NCT05879770: Wire vs Prolen

Is the Use of Prolene as Sufficient as the Use of Wire in Shouldice Surgery to Keep the Recurrence Rate Low After One Year?

Status unknown Last updated 30 May 2023
What this trial tests

trial testing suture material in Inguinal Hernia in 1,400 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
1 January 2024
1 March 2024

Quick facts

Lead sponsorShouldice Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,400
Start date1 September 2023
Primary completion1 January 2024
Estimated completion1 March 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Shouldice Hospital

Who can join

16 and older, any sex, with Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

When conducting the Shouldice procedure the 4-layer suture of the transversalis fascia is usually done with Prolene worldwide. At the Shouldice hospital the wire has originally been used for these augmentation. During the last decade several Shouldice Surgeons started to use the Prolene due to occasional delivery problems of the wire from Germany. The 1-year- recurrence rate at the Shouldice hospital is 1,15% (mainly wire-use). The published 1-year recurrence rate in Europe is 2%. As quality assessment, this project intends to evaluate these two options for suturing (wire vs Prolene) in the elective inguinal hernia patient in terms of 1-year recurrence rate. The population of focus will be those who had a primary or secondary inguinal hernia operation at Shouldice Hospital and the project is estimated to take 3 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of suture material

Trials testing the same drug.

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Shouldice Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05879770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing